Skip to main content
KEYNOTE-177 delivers final results with pembrolizumab vs chemotherapy for MSI-H or dMMR mCRC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
KEYNOTE-177 delivers final results with pembrolizumab vs chemotherapy for MSI-H or dMMR mCRC
User login
Username
Password
Reset your password
Type
Lead
score